Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2022 08:14 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark 24 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
October 17, 2022 08:36 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark 17 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
October 14, 2022 08:35 ET | Source: Novo Nordisk A/S

Novo Nordisk announces the completion of the Forma Therapeutics acquisition

Bagsværd, Denmark, 14 October 2022 – Novo Nordisk today announced that the acquisition of Forma Therapeutics Holdings, Inc. (Forma), announced on 1 September 2022, has been completed. Following the...
October 10, 2022 10:30 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark 10 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
October 03, 2022 08:36 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 3 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
October 03, 2022 08:02 ET | Source: Novo Nordisk A/S

Once-weekly insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in ONWARDS 5 phase 3a trial

Bagsværd, Denmark, 3 October 2022 – Novo Nordisk today announced headline results from the ONWARDS 5 phase 3a trial with once-weekly insulin icodec in people with type 2 diabetes. The ONWARDS 5 trial...
September 26, 2022 07:11 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 26 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
September 22, 2022 02:33 ET | Source: Novo Nordisk A/S

More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec

Data presented today show more participants achieved greater treatment satisfaction when switching to once-weekly insulin icodec in ONWARDS 2 trial Bagsværd, Denmark, Thursday 22 September 2022 –...
September 19, 2022 09:51 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 19 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
September 12, 2022 09:28 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 12 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...